|
Jun 16
|
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters
|
|
Jun 10
|
Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris
|
|
Jun 9
|
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
|
|
Apr 21
|
Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now
|
|
Apr 9
|
Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention
|
|
Apr 8
|
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
|
|
Apr 7
|
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
|
|
Apr 7
|
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
|
|
Feb 14
|
Stanley Druckenmiller's Strategic Moves: A Closer Look at Teva Pharmaceutical Industries Ltd
|
|
Feb 11
|
Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva
|
|
Jan 3
|
Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday
|
|
Oct 11
|
Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
|
|
Oct 11
|
Update: Teva Pharmaceutical to Pay $450 Million to Settle Anti-Kickback Allegations
|
|
Oct 10
|
Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations
|
|
Oct 10
|
Teva to pay $450 million to resolve US kickback, price-fixing cases
|
|
Oct 9
|
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
|
|
Oct 8
|
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
|
|
Oct 7
|
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
|
|
Oct 7
|
Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?
|
|
Jul 29
|
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
|